Back

Just - Evotec Biologics advances orthopoxvirus antibodies into Phase 1 studies

Verifying
  • Just - Evotec Biologics advanced orthopoxvirus antibodies into Phase 1 clinical studies.
  • Phase 1 is the program’s stated stage of clinical development.
  • The U.S. Department of War is identified in connection with the antibodies.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Just - Evotec Biologics advances orthopoxvirus antibodies into Phase 1 studies - CoinPost Terminal